UCSF School of Medicine
V

Trastuzumab Deruxtecan Approval for Metastatic HER2+ Bladder Cancer

By UCSF School of Medicine FEATURING Vadim Koshkin
By UCSF School of Medicine FEATURING Vadim Koshkin
0 views
June 20, 2024
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
14:16
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Mes…

Feat. E. Efstathiou
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
20:41
2024 ASCO® Annual Meeting Insights Hub

Bladder Cancer Highlights From ASCO® 2024

Feat. G. Sonpavde
09:14
Robert Dreicer

AUA Advanced Prostate Cancer Guidelines: 2023 Update

29:25
Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

15:58
Total Health

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Feat. M. Reimers
22:19
Insights from 2023 ESMO Annual Meeting

Bladder Cancer Highlights From ESMO 2023: Comparing and Contrasting …

Feat. G. Sonpavde
03:05
Benjamin L. Maughan

Testosterone Suppression and Recovery in Patients With Advanced Pros…

17:32
Kriti Mittal

Current Updates in Urothelial Cancer: Clinical Implications for Prac…

22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
09:45
Northwestern Medicine Oncology and Hematology

Differences Between Urologists and Medical Oncologists in the Manage…

Feat. W. Catalona
14:00
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Key Highlights in Bladder/Urothelial Ca…

Feat. G. Sonpavde
22:07
Weill Cornell Medicine Oncology & Hematology

Urothelial Carcinoma: New Developments

Feat. C. Sternberg
06:58
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very…

Feat. M. Zarba
19:30
Scripps Health

Sequencing 1L Therapies in Metastatic Urothelial Carcinoma

Feat. P. Grivas
06:01
ecancer

ESMO 2023 Insights: "Phase 3 EV-302 Trial - Evaluating the Comb…

Feat. T. Powles
10:19
University of Colorado Cancer Center

NCCN Guidelines Updates for the Treatment of Metastatic Urothelial C…

Feat. T. Flaig
09:00
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel + Abiratero…

Feat. C. Kyriakopoulos
30:03
UCSF School of Medicine

Recent Advances in Advanced Urothelial Cancers: Time for a New Stand…

Feat. T. Friedlander
17:33
Benjamin Garmezy

1L Treatment Approaches in aRCC: Current Data, Treatment Selection, …